Engineers Gate Manager’s Neurocrine Biosciences NBIX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $678K | Buy |
5,392
+2,273
| +73% | +$286K | 0.01% | 1330 |
|
2025
Q1 | $345K | Sell |
3,119
-15,847
| -84% | -$1.75M | 0.01% | 1632 |
|
2024
Q4 | $2.59M | Sell |
18,966
-57,656
| -75% | -$7.87M | 0.05% | 522 |
|
2024
Q3 | $8.83M | Buy |
76,622
+41,978
| +121% | +$4.84M | 0.17% | 151 |
|
2024
Q2 | $4.77M | Buy |
34,644
+17,542
| +103% | +$2.42M | 0.11% | 274 |
|
2024
Q1 | $2.36M | Buy |
17,102
+7,487
| +78% | +$1.03M | 0.06% | 419 |
|
2023
Q4 | $1.27M | Sell |
9,615
-13,205
| -58% | -$1.74M | 0.04% | 666 |
|
2023
Q3 | $2.57M | Buy |
22,820
+5,832
| +34% | +$656K | 0.09% | 291 |
|
2023
Q2 | $1.6M | Sell |
16,988
-734
| -4% | -$69.2K | 0.06% | 444 |
|
2023
Q1 | $1.79M | Buy |
17,722
+13,625
| +333% | +$1.38M | 0.07% | 343 |
|
2022
Q4 | $489K | Buy |
+4,097
| New | +$489K | 0.03% | 907 |
|
2022
Q3 | – | Sell |
-5,262
| Closed | -$513K | – | 1919 |
|
2022
Q2 | $513K | Buy |
5,262
+1,539
| +41% | +$150K | 0.02% | 1096 |
|
2022
Q1 | $349K | Buy |
3,723
+976
| +36% | +$91.5K | 0.01% | 1291 |
|
2021
Q4 | $234K | Sell |
2,747
-3,909
| -59% | -$333K | 0.01% | 1555 |
|
2021
Q3 | $638K | Sell |
6,656
-5,149
| -44% | -$494K | 0.04% | 738 |
|
2021
Q2 | $1.15M | Buy |
+11,805
| New | +$1.15M | 0.07% | 372 |
|
2020
Q4 | – | Sell |
-12,618
| Closed | -$1.21M | – | 1881 |
|
2020
Q3 | $1.21M | Buy |
12,618
+8,983
| +247% | +$864K | 0.06% | 518 |
|
2020
Q2 | $443K | Buy |
3,635
+929
| +34% | +$113K | 0.02% | 1007 |
|
2020
Q1 | $234K | Sell |
2,706
-21,399
| -89% | -$1.85M | 0.02% | 1177 |
|
2019
Q4 | $2.59M | Buy |
24,105
+18,635
| +341% | +$2M | 0.11% | 260 |
|
2019
Q3 | $493K | Buy |
+5,470
| New | +$493K | 0.03% | 789 |
|
2019
Q2 | – | Sell |
-2,400
| Closed | -$211K | – | 1302 |
|
2019
Q1 | $211K | Buy |
+2,400
| New | +$211K | 0.01% | 819 |
|